Triple approach strategy for patients with locally advanced pancreatic carcinoma.

Background: Radiofrequency ablation (RFA) is a relatively new technique, applied to metastatic solid tumours which, in recent studies, has been shown to be feasible and safe on locally advanced pancreatic carcinoma (LAPC). RFA can be combined with radio-chemotherapy (RCT) and intra-arterial plus systemic chemotherapy (IASC). The aim of this study was to investigate the impact on the prognosis of a multimodal approach to LAPC and define the best timing of RFA.

[Hip ultrasound evaluation in infancy: comparison with normal results].

We have reviewed more than a decade of clinical-echographical research in the developmental displasia of the hip (D.D.H.

Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) in locally advanced or metastatic gastric cancer: a single institution experience.

Aims And Background: The role of chemotherapy in locally advanced or metastatic gastric cancer has been controversial, but chemotherapy has recently been shown to relieve tumor-related symptoms, improve quality of life and prolong survival when compared with best supportive care. Furthermore, palliative chemotherapy is also cost-effective. "Second-generation" combination chemotherapy regimens were developed in the 1980s with high activity in advanced or metastatic gastric cancer (EAP, FAMTX, PELF, ECF).

[Cholelithiasis in pediatric age: three cases].

The cholelithiasis is a unusual pathology of paediatric age; it is exceptional pathology in the earliest childhood. The disease is often unsymptomatic and it can be correlated with several pathologies. The echography is the golden standard.

[Primary non-Hodgkin's lymphoma of the bone. Description of 2 cases].

Primary bone non Hodgkin's lymphomas (PBL) are approximately 5% of extranodal lymphomas and 5% of all primary bone tumors. A standard treatment has not been codified yet. The most received only radiotherapy but recently it was introduced combined modality treatment with radiotherapy plus chemotherapy or chemotherapy alone.